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Abstract
microRNAs (miRNA) are a class of small noncoding RNAs that regulate post-transcriptional 
expression of their respective target genes and are responsive to various stimuli, including 
lipopolysaccharide (LPS). Here we examined the early (4h) miRNA responses of THP1-
differentiated macrophages challenged with LPS derived from the periodontal pathogens, 
Aggregatibacter actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg) or environmentally 
modified LPS obtained from Pg grown in cigarette smoke extract. Predicted miRNA-gene target 
interactions for LPS-responsive miR-29b and let-7f were confirmed using dual-luciferase assays 
and by transfection experiments using miRNA mimics and inhibitors. Convergent and divergent 
miRNA profiles were observed in treated samples where differences in miRNA levels related to 
the type, concentration and incubation times of LPS challenge. Dual-luciferase experiments 
revealed miR-29b targeting of IL-6Rα and IFN-γ inducible protein 30 (IFI30) and let-7f targeting 
of suppressor of cytokine signaling 4 (SOCS4) and Thrombospondin-1 (TSP-1). Transfection 
experiments confirmed miR-29b and let-7f modulation of IL-6R and SOCS4 protein expression 
levels, respectively. Thus, we demonstrate convergent/divergent miRNA responses to wild type 
and its environmentally-modified LPS and demonstrate miRNA targeting of key genes linked to 
inflammation and immunity. Our data indicate that these LPS-responsive miRNAs may play a key 
role in fine-tuning the host response to periodontal pathogens.
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MicroRNAs (miRNA) are small, single-stranded, non-coding RNAs transcribed as mono- or 
polycistronic transcripts by RNA pol II that post-transcriptionally regulate expression of 
numerous genes.1, 2 Functional miRNAs bind various mRNAs, primarily in the 3′ 
untranslated region (UTR) leading to translation suppression or degradation of target RNA.1 
miRNAs are known to regulate diverse biological processes and recent studies have 
demonstrated their function as crucial components of innate immune responses.
Periodontal diseases are infectious, inflammatory disorders characterized by loss of the 
supporting structures of teeth. The Gram negative anaerobes Porphyromonas gingivalis (Pg) 
and Aggregatibacter actinomycetemcomitans (Aa) have been strongly implicated in the 
pathogenesis of chronic and aggressive forms of periodontal disease, respectively.3, 4 It has 
been proposed that an inefficient immune response to these bacterial species could be a 
decisive factor.5 LPS is a key virulence factor that triggers inflammatory responses. These 
pathogen-derived LPS are recognized by Toll-like receptors (TLRs) that transduce signals to 
sensitize the host. While Aa LPS is a TLR4 ligand, recognition of LPS from Pg is unusual in 
that it is believed to be mediated by TLR2, TLR4 or TLR7.6, 7 LPS derived from Pg has 
been shown to differ from enterobacterial LPS (e.g., E. coli) in structure and function; 
therefore, the TLRs and the intracellular inflammatory signaling pathways are accordingly 
different.8 This is further supported by the observation that LPS derived from Pg and C. 
ochracea act as antagonists to the TLR4 receptor.9
Cigarette smoking is considered a significant risk factor for the progression of periodontitis 
and various reports have demonstrated altered production of inflammatory cytokines in 
smokers compared to non-smokers.10, 11 It is also known that modifications to LPS structure 
occur in response to environmental pressures and stimuli which may alter the host 
response.12-14 Clinically, a significant increase in the long-chain fatty acids associated with 
anaerobic bacterial periodontopathogens, particularly, in the 3-OH-Ci17.0 and decrease in the 
3-OH-C12.0 and 3-OH-C14.0 were observed in salivary samples from smokers compared to 
their healthy counterparts.15 Further, mass spectrometry of LPS isolated from Pg grown in 
cigarette smoke extract (CSE) revealed that the lipid A fatty acid profile differed from wild 
type (WT) LPS.15 Lipid A is a highly conserved moiety and is the minimal component of 
LPS that engenders its inflammatory potential. Thus, altered production of the 
proinflammatory response in smokers could be a manifestation of altered LPS structure 
which may prevent TLRs to precisely trigger downstream signaling.
Macrophages are multifunctional cells and key components of the innate immune response. 
They respond to LPS and activate several host defense functions through production of 
inflammatory mediators. We previously reported the presence of CD68+ macrophages in 
periodontally-involved human tissues and their rapid and aggressive capacity to respond to 
Pg LPS in-vitro highlighting their involvement in host defense and disease progression.16 
Several lines of evidence indicate a role of miRNA in inflammatory responses, primarily by 
regulating the levels of TLR signaling components and immunomodulatory genes in 
macrophages.17 For instance, LPS-inducible miR-146a downregulates TNF receptor-
associated factor 6 (TRAF6), interleukin-1 receptor-associated kinase 1 (IRAK1) and tumor 
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necrosis factor alpha (TNF-α) that renders cells refractive to further stimuli, while miR-21 
regulates expression of programmed cell death 4 (PDCD4), a proinflammatory protein 
which induces NF-κB and IL-6 production.17-18 On the other hand, miR-19 targets several 
negative regulators of NF-κB signaling including tumor necrosis factor, alpha-induced 
protein 3 (TNFAIP3), Lysine-specific demethylase 2a (KDM2a), Zinc finger and BTB 
domain-containing protein 16 (ZBTB16) and RING finger protein 11 (RNF11).19 Thus, 
miRNAs can act as both negative and positive regulators of LPS signaling. However, 
whether the degree of macrophage responsiveness to different sources of LPS is equivalent 
to or varies with the source of LPS remains unclear.
Here, we examined the extent of human macrophage miRNA responses to Aa and Pg LPS. 
Moreover, to study the impact of altered LPS structure on global miRNA expression, LPS 




Porphyromonas gingivalis strain W83 was grown in the presence or absence of cigarette 
smoke extract as previously described.13, 14, 20 Briefly, Pg cultures were grown to mid- to 
late exponential phase (O.D.600nm = 1.0; ≈ 1 × 109 cells ml-1) in Gifu Anaerobe Medium 
(GAM, Nissui Pharmaceutical, Tokyo, Japan) or in GAM-CSE under anaerobic conditions 
(80% N2, 10% H2, 10% CO2) at 37°C in a Coy Laboratories anaerobic chamber (Coy 
Laboratory Products, Grass Lake, MI, USA). For Pg-CSE cultures, GAM was conditioned 
using standard reference cigarettes (Kentucky Tobacco Research and Development Center, 
Lexington, KY, USA) and diluted to 4000 ng/ml nicotine equivalents prior to use.21-24 LPS 
was extracted using the LPS extraction kit (iNtron Biotechnology, Kyunggi-do, Korea) 
according to manufacturer’s instructions. LPS from Aggregatibacter 
actinomycetemcomitans strain Y4 (serotype B) was extracted and purified as previously 
described.25-27 LPS was found to containing <0.001% nucleic acid and 0.7% protein by 
spectrophotometry and bicinchoninic acid protein assay, respectively.
Cell culture and differentiation
The THP1 cell line was procured from the UNC Lineberger Comprehensive Cancer Center 
Tissue Culture Facility (UNC at Chapel Hill, Chapel Hill, NC, USA) and maintained at 
2×105 cells/ml in RPMI 1640 medium supplemented with 10% FCS and 2 mmol/L L-
glutamine, penicillin (100 U/ml) and streptomycin (100 μg/ml). THP1 cells (2×105/ml) were 
differentiated using 50 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich, St 
Louis, MO, USA) for 3d. Differentiation of PMA treated cells was enhanced after the initial 
3d stimulus by removing the PMA-containing media and washing twice with PBS before 
adding fresh RPMI 1640 (10% FCS, 1% L-glutamine). The following day, media was 
replaced with complete RPMI containing Aa, Pg or Pg-CSE LPS at 50ng/ml-1000ng/ml as 
indicated. Incubation periods ranged from 1 - 24 hours.
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Total RNA was isolated using the miRNeasy kit (Qiagen, Germantown, MD, USA) 
following manufacturer’s protocol. The RNA was quantitated using the NanoDrop (Thermo 
Scientific, Wilmington, DE, USA) and integrity assessed using the 2100 Bioanalyzer 
(Agilent, Foster City, CA, USA).
NanoString nCounter miRNA assay
To examine the early (4h) miRNAs responses of differentiated macrophages to LPS 
challenge, global miRNA profiling was performed using the Nanostring nCounter 
technology, a multiplexed, color-coded probe assay. One hundred nanograms of total RNA 
were used to generate cDNA libraries according to the manufacturer’s instructions. Ligation 
reactions, purification and dilution of probes were performed according to the 
manufacturer’s instructions (www.nanostring.com). Hybridization reactions were performed 
according to the manufacturer’s instructions with 5 mL of the fivefold diluted sample 
preparation reaction. All hybridization reactions were incubated at 65°C for a minimum of 
18 h. Hybridized probes were purified and counted on the nCounter Prep Station and Digital 
Analyzer (NanoString, Technologies, Seattle, WA, USA) at Lineberger Comprehensive 
Cancer Center following the manufacturer’s instructions. For each assay, a high-density scan 
(600 fields of view) was performed.
NanoString nCounter miRNA data analysis
Data normalization was performed according to manufacturer’s instructions. Briefly, 
NanoString nCounter miRNA raw data was normalized for lane-to-lane variation with a 
dilution series of six spike-in positive controls. The sum of the positive controls for a given 
lane was divided by the average sum across lanes to yield a normalization factor, which was 
then multiplied by the raw counts in each lane to give normalized values. The sum of five 
different endogenous controls were then averaged and normalized across the samples. The 
values obtained were averaged for LPS treated and untreated samples. Fold change was 
calculated as the ratio of LPS treated versus untreated control sample. For each treatment 
miRNAs with fold changes ≥1.45 or ≤ 0.6 were categorized as deregulated. The data has 
been deposited in the Gene Expression Omnibus (GEO) public database under the 
Accession Number GSE43411.
Quantitative real-time PCR
For pri-miRNA quantification, 1 microgram total RNA was reverse transcribed using the 
Superscript RT-II kit (Life Technologies, Grand Island, NY, USA). A 20 μl reaction mix 
was prepared using 2X EvaGreen Master Mix (Biotium, Hayward, CA, USA), 1-2 μl of 
cDNA, and 10 pmoles of each forward and reverse primer (Supplemental Table 1). The real-
time PCR was carried out in a StepOne 7500 thermocycler (Applied Biosystems, Carlsbad 
CA, USA). GAPDH served as an internal control and all reactions were run in triplicates. 
For mature miRNA quantification, miScript primers and miScript II RT Kit were purchased 
from Qiagen. One hundred nanograms of total RNA was reverse transcribed according to 
manufacturer’s instructions. The reactions were run using miRNA specific primers and 
universal primer in the PCR mix buffer. RNU6B was used as endogenous control. The Ct 
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values of replicates were analyzed to calculate relative fold change using the delta-delta Ct 
method. 28
ELISA
The concentrations of IL6 in the culture medium were quantified by specific human IL6 
enzyme-linked immunosorbent assays (ELISA; Invitrogen, CA, USA) as per manufacturer’s 
instructions. The absorbance was measured at 450nm on SpectraMax® M2 (Molecular 
Devices, Sunnyvale, CA, USA).
Bioinformatic miRNA target predictions and seed match analyses
miRWalk (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/mirnatargetpub.html) 29 
was used to predict the miRNA binding sites of candidate gene 3′UTR using the 8 
established miRNA-target prediction algorithms. Genes that were highlighted in at least 5 of 
the 8 algorithms were selected for further study. For screening, miRNA binding sites on 7 
different 3′UTRs (three genes for let-7f and four genes for miR-29b) linked to immunity/
inflammation by Gene Ontology (GO) biological terms (http://www.geneontology.org/) 
were selected.
Luciferase reporter constructs and dual luciferase reporter assays
Genomic DNA was isolated from freshly prepared PBMCs using QIAamp DNA mini kit 
(Qiagen) according to manufacturer’s instructions. The 3′UTRs of predicted miRNA target 
genes were PCR amplified using Phusion Taq polymerase (NEB, Ipswich, MA, USA). The 
sequence of primers and expected amplicon size is listed in Supplemental Table 2. The 
amplified products were digested with XhoI and NotI and ligated downstream to the 
luciferase reporter gene in psiCHECK™-2 vector (Promega, Madison, WI, USA). The 
colonies were screened by restriction digestion and three positive clones for each gene were 
verified by DNA sequencing. Dual experiments were carried out in a 48-well format. In 
brief, HEK293 cells were seeded at the density of 3×104 in DMEM supplemented with 10% 
fetal bovine serum. All the transfections were performed in quadruplicate using 0.5 μL 
Lipofectamine 2000 (Invitrogen, Grand Island, NY, USA), 120 ng dual luciferase reporter 
plasmids, and a final concentration of 1pmol, 5pmol or 10pmol of synthetic miRNA mimics 
(Thermo Fisher Scientific, Lafayette, CO, USA). As negative controls we used: 1) Empty 
vectors + miRNA mimics and, 2) reporter constructs + miRIDIAN microRNA Mimic 
Negative Control #1 (Thermo Fisher Scientific). After 36 h post-transfection, cells were 
lysed in passive lysis buffer (Promega) and dual luciferase assays (Promega) were 
performed using the Lumat (Turner BioSystems, Sunnyvale, CA, USA) luminometer. For 
each reporter 3′UTR construct, the Rluc/Fluc value obtained was normalized to the value 
obtained for psiCHECK™-2 no-insert control (EV) co-transfected with the same miRNA 
mimic. The values obtained were plotted as histograms, where EV is set at 1.
MTS assay
Cell viability was determined using the CellTiter 96 AQueous Cell Proliferation Assay Kit 
(Promega) according to manufacturer’s instructions. THP1 differentiated macrophages were 
transfected with miRNA mimics or inhibitors at 40 nM concentrations. A total of 20 μl of 
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MTS reagent was added to each well and incubated for two hours. Absorbance at 490 nm 
was monitored using the SpectraMax® M2 (Molecular Devices, Sunnyvale, CA, USA) plate 
reader.
Transfection of THP1-differentiated macrophages with miRNA mimics and inhibitors
THP1 cells were cultured as described above. Differentiated macrophages were transfected 
with miRNA mimics or miRNA inhibitor using HiPerfect reagent (Qiagen) according to 
manufacturer’s instructions. Briefly, 1×106 cells were seeded in 6-well plates and 
transfected with miRNA mimics or inhibitor at indicated concentrations. After 36 hours, 
cells were harvested for protein detection or RNA isolation. The transfection efficiency of 
miRNAs was determined by miScript primer assay for miR-29b as described above.
Western blotting
Differentiated macrophages transfected with miRNA mimics/ inhibitors or controls were 
lysed using passive lysis buffer (Promega) supplemented with protease inhibitor cocktail 
(Roche, Indianapolis, IN, USA). The blots were incubated with IL-6Rα (rabbit polyclonal), 
SOCS4 (mouse polyclonal) and GAPDH (rabbit polyclonal) primary antibodies (Abcam, 
Cambridge, MA, USA) at 1:1000 dilution. Images were captured on the Odyssey® Two-
Color Infrared Imaging System (LI-COR Biotechnology, Lincoln, NE, USA) using 
manufacturer’s instructions. ImageJ software (http://rsbweb.nih.gov/ij/) was used to quantify 
the results. The values for each lane was normalized with respect to endogenous control 
GAPDH and compared with the negative control mimic transfection.
Statistics
Data were analyzed using GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Mean 
values, error bars (standard deviation), and Student’s t-test (two-tailed) were calculated from 
three independent experiments. A P value of < 0.05 was considered significant.
Results
LPS of periodontal pathogens induces convergent and divergent miRNA profiles
We profiled 664 different miRNAs using Nanostring assay, of which expression of ~200 
(30%) miRNAs were detected across all samples. These were categorized as no change, 
upregulated or downregulated compared to untreated controls (Figure 1A). While the 
majority of miRNAs were constitutively expressed and did not exhibit change in expression 
levels compared to untreated controls, a subset of miRNAs were LPS-responsive and 
differentially expressed (17.3% - 29%). Compared with Aa LPS (11.2%), challenge with Pg 
LPS or Pg-CSE LPS resulted in a higher percentage of downregulated miRNAs (22.2% and 
18.6%, respectively). Figure 1B diagrams the distribution of overlapping and unique 
miRNAs responsive to each LPS. It can be noted that 24 miRNAs were differentially 
expressed across all 3 LPS species forming what may appear to be a “core” miRNA 
response, the majority of which were downregulated. Nonetheless, LPS-specific miRNA 
responses were also evident. Quantitative PCR data corroborated with Nanostring miRNA 
profiling data in that let-7f, miR-29b, miR-32 and miR-891a were downregulated (P< 0.05) 
upon LPS challenge while miR-16 levels did not change (data not shown). The levels of 
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miR-146a were induced in all LPS treatments and although a similar trend was noted, only 
Aa LPS demonstrated increased levels of miR-146a in the Nanostring profiling.
To investigate if the observed changes in mature miRNA levels correspond to the precursor 
transcript expression, pri-miRNA levels of 4 representative miRNAs (miR-146a (up), let-7f, 
miR-32 (down) and miR-16 (no change)) were analyzed. Pri-miR-16, pri-miR-32 and pri-
miR-146a levels corroborate with their respective mature miRNAs (P< 0.05, data not 
shown) indicating that the response of these miRNAs to LPS is a transcriptional event. 
However, the pri-let-7f levels were increased in response to LPS while the corresponding 
mature miRNA levels were reduced (P< 0.05, data not shown). Similarly, a significant 
change in pri-miR-16 levels in Aa LPS and Pg CSE LPS treatment was evident while mature 
miR-16 expression was not affected by any of the LPS treatments.
An in-silico search identified various cytokines and transcription factors as validated targets 
for miRNAs induced specifically by Pg-CSE LPS (Supplementary Table 3). Of note, IL-6 
levels have been reported to negatively correlate with miR-99a levels, 30 a miRNA 
specifically induced (~1.6 fold) by Pg-CSE LPS in our study. In agreement, supernatant 
levels of IL-6 were 3 times lower in Pg-CSE LPS-treated macrophages compared to Pg 
LPS-treated macrophages (P< 0.001, Supplementary Figure 1).
miRNAs respond to LPS challenge dose and incubation time
To study the expression kinetics of selected LPS-responsive miRNAs (miR-29b, miR-32 
and miR-891 (downregulated) and miR-146a (upregulated)), we monitored their levels 
across 1, 4, and 24 hours of LPS stimulation. Expression changes in the levels of miR-29b, 
miR-32 and miR-891 were observed at 1h suggesting that these are among the immediately 
responsive miRNAs (Figure 2A). While the levels of miR-29b and miR-32 decreased over 
time, a greater reduction in miR-29b levels was noted in Pg-CSE-treated samples. miR-891 
expression did not change significantly over the course of 24h. The expression of miR-146a 
was significantly induced at 4h, the levels of which increased remarkably at 24h, particularly 
in Pg-CSE-treated samples.
To investigate the possibility that these miRNAs were also responsive to the LPS dose, 
miRNA levels were analyzed after a 4h treatment with either 50 ng/ml or 1000 ng/ml of 
LPS. We noted miRNA–specific effects based on the challenge dose (Figure 2B). For 
instance, miR-29b and miR-32 were maximally downregulated at the higher dose compared 
to the lower dose of Aa LPS (P < 0.05). No significant changes were observed for either 
miR-146a or miR-891 (P > 0.05) although a similar downward trend was noted for 
miR-891at the higher dose of Aa LPS. Except for miR-146a, challenge with Pg- and Pg-
CSE also resulted in downregulation of miR-29b, miR-32 and miR-891. Conversely, the 
higher dose of Pg and Pg-CSE LPS, but not Aa LPS upregulated levels of miR-146a. 
Interestingly, Pg-CSE LPS elevated miRNA-146a levels to a higher degree than did Pg-LPS 
(P< 0.01) further indicating that macrophages respond differently to environmentally 
modified LPS. Overall, our results demonstrate a convergent/divergent miRNA profile 
based on the type of LPS challenge, the intensity of which varied both with time and 
concentration.
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LPS challenge downregulates miRNAs targeting genes involved in immunoregulation
As discussed above, LPS challenge primarily downregulated miRNAs expression (Figure 1). 
To examine the functional aspect of this event, an in-silico approach was employed to 
identify target genes of miR-29b and let-7f. Importantly, all of the selected 3′UTRs 
examined had only one miRNA binding site to be tested. Figure 3 shows pairwise alignment 
of miRNAs with their predicted gene targets. The luciferase assays demonstrate that of the 7 
in-silico interactions examined, four showed significant reduction (~30-60%, P < 0.01) in 
luciferase activity. These include let-7f targeting of Thrombospondin-1 (TSP-1) and 
Suppressor of Cytokine Signaling 4 (SOCS4) 3′UTR (Figure 3A-D) and miR-29b targeting 
of IL-6Rα and Interferon-Gamma Inducible Protein (IFI30) (Figure 3E-H). Further, 
increasing miRNA mimic concentrations to 5 pmol maximally reduced the luciferase 
activity of SOCS4 and IL-6Rα transfectants; however, increasing miRNA mimic 
concentration to 10 pmol had no significant effect on luciferase activity (Figure 3D, F; bars 
3-5). Co-transfection with negative control miRNA mimic had no effect on the luciferase 
activity confirming the miRNA sequence specificity in targeting the 3′UTRs. Finally, 
transfection of miRNA mimics or negative control miRNA had no effect on the viability of 
HEK293 cells as observed from MTS assay (data not shown).
miRNA mimics modulate expression of target proteins linked to the immune response
To confirm that LPS-responsive miRNAs can modulate protein levels of target genes, 
differentiated macrophage cultures were transfected with mimic miRNAs or their specific 
inhibitors and monitored levels of target proteins. We observed ~14 fold increase in 
miR-29b levels compared to untransfected control (data not shown). Figure 4A shows a 
significant reduction in IL-6Rα protein in cells transfected with miR-29b mimic in a dose-
dependent manner. Co-transfection with miRNA inhibitor rescued miR-29b regulation of 
IL-6Rα as noted by the higher protein levels compared to mimic-only transfection, but 
comparable to negative miRNA mimic transfection. Similarly, transfection of let-7f mimics 
reduced SOCS4 protein levels by two-fold but not in the presence of miRNA inhibitors 
(Figure 4B). The transfection with mimics or inhibitors had no apparent effect on the 
viability of the cells as observed by MTS assay (Supplementary Figure 2). These results 
confirm that IL-6Rα and SOCS4 are direct targets of miR-29b and let-7f, respectively.
Discussion
The binding of LPS to TLRs initiates signaling cascades that trigger the host response 
against invading pathogens. Numerous studies on TLR4 ligands have revealed the 
mechanistic aspect of this interaction and only recently has the miRNA response begun to be 
characterized. 17, 18, 31 Currently very little is known about these responses to periodontal 
pathogens. Given the fact that activation of different TLRs may affect downstream 
signaling, we sought to compare the extent to which miRNA profiles are impacted by 
differences in TLR ligands and to examine the regulation of predicted gene targets by LPS-
responsive miRNAs. Further, environmentally-induced alterations in LPS structure may 
modify TLR signaling and thus miRNA levels, which prompted us to include Pg-CSE LPS, 
an LPS derived from Pg grown in cigarette smoke extract.13 Of note, CSE has been reported 
to alter gene expression patterns of Pg.13, 14 In salivary samples derived from smokers, 
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Buduneli and colleagues reported a significant increase in the long-chain fatty acids 
associated with anaerobic bacterial periodontopathogens,15 However, the degree to which 
CSE alters LPS structure is not completely understood and is the subject of ongoing 
investigation (D.A. Scott, personal communication).
This study identified IL-6Rα as a novel target of miR-29b. LPS treatment leads to a 
reduction in miR-29b which may limit post-transcriptional modulation of IL-6Rα 
expression. IL-6Rα is found as either membrane bound or soluble (sIL-6R) forms, both of 
which can potentiate IL-6 signaling. LPS treatment of differentiated macrophages induces 
levels of otherwise undetectable IL-6 while sIL-6R is reported to increase in certain 
inflammatory conditions. 32 Importantly, IL-6R trans-signaling is required for the active 
recruitment of monocytes at the site of inflammation.33 Unlike ubiquitously expressed 
gp130, IL-6Rα has restricted expression on myeloid cells including monocytes and 
macrophages. Thus, IL-6Rα could play a decisive role in IL-6 signaling and our results 
suggest that downregulation of miR-29b could contribute to this pathway. Moreover, a 
recent study has reported that miR-29b regulates transcript levels of TNFAIP3 encoded A20, 
a negative regulator of NF-kB signaling, 34 further indicating that reduced expression of 
miR-29b upon LPS stimulation is required for active pro-inflammatory NF-kB signaling. 
Together, these results show that miR-29b is an important component of the inflammatory 
response.
The SOCS family of proteins regulates cytokine signaling by dephosphorylation of JAKs 
and thus plays a key role in maintaining the homoeostasis of immunological responses. 
These proteins are induced upon LPS stimulation and various miRNAs have been shown to 
differentially regulate SOCS family transcripts. 35-37 Recently, miR-98 and let-7 family 
members have been shown to modulate SOCS4 during Cryptosporidium parvum 
infection. 38 The let-7 family is downregulated in response to C. parvum thereby inducing 
SOCS4 expression. Similarly, our data demonstrates that let-7f, which is downregulated in 
response to LPS derived from oral pathogens, targets the 3′UTR of SOCS4. There are three 
known binding sites for let-7 family located at the 1843-1850, 2820-2826 and 3668-3675 nt 
positions of the SOCS4 3′UTR. Hu et al., 39 reported let-7f targeting of SOCS4 at the highly 
conserved 1843-1850 3′UTR position. We screened the let-7f interaction that encompasses 
only the 3668-3675 binding site and provide evidence for a novel functional binding site for 
let-7f on the SOCS4 3′UTR. In agreement, overexpression of let-7f in THP-1 differentiated 
macrophages leads to a reduction in SOCS4 protein levels, which was abolished in presence 
of let-7f inhibitors. Although our study did not specifically investigate the contribution of 
each let-7 binding to the target sites on SOCS4 3′UTR, it is known that miRNAs bind to 
multiple sites on target genes and act cooperatively to fine tune protein levels. 1
Our results also demonstrate that let-7f regulates thrombospondin-1 (TSP-1), a matricellular 
protein expressed at sites of tissue damage and myeloid-cell influx in response to innate and 
inflammatory signalling. 39 It has been previously reported that TSP-1 and let-7f exhibit 
antagonistic expression levels, 40,41 but our results provide evidence for direct let-7f 
modulation of TSP-1. TSP-1 is a regulator of inflammation that can be pro- or anti-
inflammatory depending upon the context in which it is expressed. On the one hand TSP-1 
promotes the recruitment of monocytes and macrophages to sites of inflammation while 
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increasing T-cell retention, 42 and if these cells are pro-inflammatory in nature, i.e. 
comprises classically-activated macrophages or Th1 & Th17 cells, then TSP-1 can be 
considered to be part of the pro-inflammatory response. However during catabasis these 
cells are either absent, suppressed, or their phenotype is switched to being anti-
inflammatory, and TSP-1 also contributes to these processes, partly due to the importance of 
TSP-1 in activating latent TGF-β.43
Macrophages present MHC class II antigens to stimulate CD4+ T-cells. The processing of 
endocytosed antigens occurs in lysosomes and is mediated by lysosomal thiol reductase or 
interferon, gamma-inducible protein 30 (IFI30) via reduction of protein disulphide 
linkages. 44 LPS-induced cytokines are shown to stimulate IFI30 production. 45 Here our 
data show direct regulation of IFI30 by miR29b. Ugalde et al., 46 had previously reported 
this interaction in the mouse which we now extend to human IFI30 3′UTR. Therefore, a 
decrease in miR-29b levels in response to LPS may lead to an increase in IFI30 levels that 
may facilitate antigen presentation and may augment the host response against pathogens.
LPS from periodontal pathogens elicited TLR-mediated transcriptional changes in miRNA 
expression. Of note, similar changes in both mature and pri-miRNA levels for miR-32, 
miR-16 and miR-146a were identified. Induction of miR-146a levels and the concomitant 
secretion of TNF-α are considered hallmarks of LPS stimulation. 17 Aa LPS treated samples 
released high amount of TNF-α (data not shown) that correlated with elevated levels of both 
pri- and mature miR-146a. Interestingly, Pg-CSE LPS surpassed WT Pg LPS in miR-146a 
induction. These results indicate that environmentally induced changes in LPS structure alter 
the miRNA response relative to WT LPS. Our results also suggest that LPS-responsive 
miRNA is subject to additional regulatory mechanisms as evident by differences in mature 
and precursor levels of let-7f and miR-16. Indeed, modulations in miRNA processing have 
been reported during the inflammatory response. For instance, inflammation-responsive p53 
and TGF-β-induced SMAD interact with the Drosha-microprocessor complex to enhance 
pre-miRNA processing. 47,48
This study has limitations. A comparison of Pg to Pg-CSE LPS but not Aa to Aa-CSE LPS 
was made. Since smoking is recognized as a significant risk factor in the progression of 
periodontitis, additional studies incorporating CSE-modified LPS and other pathogen-
associated molecular patterns (PAMPs) will shed further light on the impact of 
environmental pressures on the host response. Moreover, due to the lack of structural data, it 
is not possible to directly relate differences in miRNA expression to CSE-induced structural 
modifications to LPS. Elucidation of these modifications will likely help explain differences 
in expression profiles identified in our study. We also did not incorporate “ultrapure” LPS in 
our study. Although LPS was carefully extracted to exclude protein and nucleic acid 
contaminants, it is possible that our results reflect macrophage responses to minute 
concentrations of these factors.
Finally, the dominant trend among the LPS-responsive miRNAs was a downregulation of 
expression, the outcome of which will likely facilitate translation of mRNA transcripts 
generated as a part of immune response. Of these an appreciable number of miRNAs 
commonly expressed among the 3 different groups are suggestive of an early miRNA “core” 
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response. Our data also revealed the downregulation of 14 miRNAs unique to Pg and Pg-
CSE LPS. This may be attributed to their common origin and to differences in TLR 
specificity. Indeed, unlike Aa LPS which is a TLR4 agonist, Pg LPS can bind to and elicit 
TLR2, TLR4 and TLR7 signaling. 7 Conversely, there were 15 miRNAs induced 
specifically in response to Pg-CSE. Taken together, these results demonstrate convergent 
and divergent miRNA expression patterns as a function of LPS treatment. These miRNAs 
may constitute potential therapeutic candidates for the design of strategies aimed at 
mitigating or stimulating immune responses for various human diseases.
Conclusion
This study demonstrates that LPS derived from Aa, Pg and Pg-CSE induces convergent/
divergent miRNA responses in human macrophages. CSE-modified LPS alters the miRNA 
responses induced by its WT derivative and that LPS-responsive miR-29b and let-7f target 
IL6Rα and SOCS4, respectively, 2 key genes linked to inflammation and immunity. 
Together, these observations highlight miRNAs as integral components in fine-tuning the 
innate response to periodontal pathogens. Further investigation regarding the 
immunomodulatory role of these miRNAs is indicated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We would like to thank Drs. Keith Kirkwood (University of South Carolina) and David A. Scott, (University of 
Louisville) for their kind gifts of purified Aa and Pg / Pg-CSE LPS, respectively.
Funding
This study was supported by the National Institute of Dental & Craniofacial Research of the National Institutes of 
Health [R01DE021052].
References
1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215–233. 
[PubMed: 19167326] 
2. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev. 2009; 10:126–139.
3. Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: 
the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol. 
2000; 38:72–122.
4. Fine DH, Markowitz K, Furgang D, et al. Aggregatibacter actinomycetemcomitans and its 
relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially 
healthy adolescents. J Clin Microbiol. 2007; 45:3859–3869. [PubMed: 17942658] 
5. Diehl SR, Wu T, Burmeister JA, et al. Evidence of a substantial genetic basis for IgG2 levels in 
families with aggressive periodontitis. J Dent Res. 2003; 82:708–712. [PubMed: 12939355] 
6. Darveau RP, Pham TT, Lemley K, et al. Porphyromonas gingivalis lipopolysaccharide contains 
multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect 
Immun. 2004; 72:5041–5051. [PubMed: 15321997] 
Naqvi et al. Page 11













7. Zhou Q, Amar S. Identification of signaling pathways in macrophage exposed to Porphyromonas 
gingivalis or to its purified cell wall components. J Immunol. 2007; 179:7777–7790. [PubMed: 
18025224] 
8. Martin M, Katz J, Vogel SN, Michalek SM. Differential induction of endotoxin tolerance by 
lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol. 
2001; 167:5278–5285. [PubMed: 11673543] 
9. Yoshimura A, Kaneko T, Kato Y, Golenbock DT, Hara Y. Lipopolysaccharides from 
periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists 
for human toll-like receptor 4. Infect Immun. 2002; 70:218–225. [PubMed: 11748186] 
10. Calsina G, Ramon JM, Echeverria JJ. Effects of smoking on periodontal tissues. J Clin 
Periodontol. 2002; 29:771–776. [PubMed: 12390575] 
11. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits expression 
of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in 
alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol. 2007; 179:6097–
6106. [PubMed: 17947684] 
12. Al-Qutub MN, Braham PH, Karimi-Naser LM, et al. Hemin-dependent modulation of the lipid A 
structure of Porphyromonas gingivalis lipopolysaccharide. Infect Immun. 2006; 74:4474–4485. 
[PubMed: 16861633] 
13. Bagaitkar J, Williams LR, Renaud DE, et al. Tobacco-induced alterations to Porphyromonas 
gingivalis-host interactions. Environ Microbiol. 2009; 11:1242–1253. [PubMed: 19175666] 
14. Bagaitkar J, Demuth DR, Daep CA, et al. Tobacco upregulates P. gingivalis fimbrial proteins 
which induce TLR2 hyposensitivity. PLoS One. 2010; 5:e9323. [PubMed: 20454607] 
15. Buduneli N, Larsson L, Biyikoglu B, et al. Fatty acid profiles in smokers with chronic 
periodontitis. J Dent Res. 2011; 90:47–52. [PubMed: 21041552] 
16. Nares S, Moutsopoulos NM, Angelov N, et al. Rapid myeloid cell transcriptional and proteomic 
responses to periodontopathogenic Porphyromonas gingivalis. Am J Pathol. 2009; 174:1400–
1414. [PubMed: 19264901] 
17. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA 
miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad 
Sci USA. 2006; 10:12481–12486. [PubMed: 16885212] 
18. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting 
of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010; 
11:141–147. [PubMed: 19946272] 
19. Gantier MP, Stunden HJ, McCoy CE, et al. A miR-19 regulon that controls NF-κB signaling. 
Nucleic Acids Res. 2012; 40:8048–8058. [PubMed: 22684508] 
20. Bagaitkar J, Daep CA, Patel CK, et al. Tobacco smoke augments Porphyromonas gingivalis-
Streptococcus gordonii biofilm formation. PLoS One. 2011; 6:e27386. [PubMed: 22110637] 
21. McGuire JR, McQuade MJ, Rossmann JA, et al. Cotinine in saliva and gingival crevicular fluid of 
smokers with periodontal disease. J Periodontol. 1989; 60:176–181. [PubMed: 2656979] 
22. Chen X, Wolff L, Aeppli D, et al. Cigarette smoking, salivary/gingival crevicular fluid cotinine 
and periodontal status. A 10-year longitudinal study. J Clin Periodontol. 2001; 28:331–339. 
[PubMed: 11314889] 
23. Fraser HS, Palmer RM, Wilson RF, Coward PY, Scott DA. Elevated systemic concentrations of 
soluble ICAM-1 (sICAM) are not reflected in the gingival crevicular fluid of smokers with 
periodontitis. J Dent Res. 2001; 80:1643–1647. [PubMed: 11597025] 
24. Scott DA, Palmer RM, Stapleton JA. Validation of smoking status in clinical research into 
inflammatory periodontal disease. J Clin Periodontol. 2001; 28:715–722. [PubMed: 11442730] 
25. Rogers JE, Li F, Coatney DD, et al. A p38 mitogen-activated protein kinase inhibitor arrests active 
alveolar bone loss in a rat periodontitis model. J Periodontol. 2007; 78:1992–1998. [PubMed: 
18062121] 
26. Rossa C Jr, Liu M, Kirkwood KL. A dominant function of p38 mitogen-activated protein kinase 
signaling in receptor activator of nuclear factor-kappaB ligand expression and osteoclastogenesis 
induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide. J 
Periodontal Res. 2008; 43:201–211. [PubMed: 18302623] 
Naqvi et al. Page 12













27. Liu D, Xu JK, Figliomeni L, et al. Expression of RANKL and OPG mRNA in periodontal disease: 
possible involvement in bone destruction. Int J Mol Med. 2003; 11:17–21. [PubMed: 12469211] 
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative 
PCR and the 2-[Delta][Delta]CT Method. Methods. 2001; 25:402–408. [PubMed: 11846609] 
29. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk--database: prediction of possible miRNA 
binding sites by “walking” the genes of three genomes. J Biomed Inform. 2011; 44:839–847. 
[PubMed: 21605702] 
30. Estep M, Armistead D, Hossain N, et al. Differential expression of miRNAs in the visceral adipose 
tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2010; 32:487–
497. [PubMed: 20497147] 
31. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following 
lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to 
endotoxin shock. J Immunol. 2007; 179:5082–5089. [PubMed: 17911593] 
32. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin-6 trans signaling suppresses T-cell 
resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn’s disease and 
experimental colitis in vivo. Nature Med. 200; 6:583–588. [PubMed: 10802717] 
33. Chalaris A, Rabe B, Paliga K, et al. Apoptosis is a natural stimulus of IL6R shedding and 
contributes to the proinflammatory trans-signaling function of neutrophils. Blood. 2007; 
110:1748–1755. [PubMed: 17567983] 
34. Graff JW, Dickson AM, Clay G, McCaffrey AP, Wilson ME. Identifying functional microRNAs in 
macrophages with polarized phenotypes. J Biol Chem. 2012; 287:21816–21825. [PubMed: 
22549785] 
35. Kinjyo I, Hanada T, Inagaki-Ohara K, et al. SOCS1/JAB is a negative regulator of LPS-induced 
macrophage activation. Immunity. 2002; 17:583–591. [PubMed: 12433365] 
36. Stoiber D, Kovarik P, Cohney S, et al. Lipopolysaccharide induces in macrophages the synthesis of 
the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the 
activating factor IFN-gamma. J Immunol. 1999; 163:2640–2647. [PubMed: 10453004] 
37. Lu C, Huang X, Zhang X, et al. miR-221 and miR-155 regulate human dendritic cell development, 
apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood. 2011; 
117:4293–4303. [PubMed: 21355095] 
38. Hu G, Zhou R, Liu J, Gong AY, Chen XM. MicroRNA-98 and let-7 regulate expression of 
suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium 
parvum infection. J Infect Dis. 2010; 202:125–135. [PubMed: 20486857] 
39. Fordham JB, Hua J, Morwood SR, et al. Environmental conditioning in the control of macrophage 
thrombospondin-1 production. Sci Rep. 2012; 2:512. [PubMed: 22803005] 
40. Sundaram P, Hultine S, Smith LM, et al. p53-responsive miR-194 inhibits thrombospondin-1 and 
promotes angiogenesis in colon cancers. Cancer Res. 2011; 71:7490–7501. [PubMed: 22028325] 
41. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial 
microRNA expression and angiogenesis. Circ Res. 2007; 101:59–68. [PubMed: 17540974] 
42. Mansfield PJ, Suchard SJ. Thrombospondin promotes chemotaxis and haptotaxis of human 
peripheral blood monocytes. J Immunol. 1994; 153:4219–4129. [PubMed: 7930624] 
43. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of 
TGF-beta1 in vivo. Cell. 1998; 93:1159–1170. [PubMed: 9657149] 
44. Maric M, Arunachalam B, Phan UT, et al. Defective antigen processing in GILT-free mice. 
Science. 2001; 294:1361–1365. [PubMed: 11701933] 
45. Lackman RL, Cresswell P. Exposure of the promonocytic cell line THP-1 to Escherichia coli 
induces IFN-γ-Inducible lysosomal thiol reductase expression by inflammatory cytokines. J 
Immunol. 2006; 177:4833–4840. [PubMed: 16982925] 
46. Ugalde AP, Ramsay AJ, de la Rosa J, et al. Aging and chronic DNA damage response activate a 
regulatory pathway involving miR-29 and p53. EMBO J. 2011; 30:2219–2232. [PubMed: 
21522133] 
47. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA 
maturation. Nature. 2008; 454:56–61. [PubMed: 18548003] 
Naqvi et al. Page 13













48. Suzuki HI, Yamagata K, Sugimoto K, et al. Modulation of microRNA processing by p53. Nature. 
2009; 460:529–533. [PubMed: 19626115] 
Naqvi et al. Page 14














Differential expression of miRNAs in response to LPS treatment. (A) Total RNA from 
differentiated THP1 cells treated with Aa LPS, Pg LPs and Pg (CSE) LPS was profiled for 
miRNAs using Nanostring technology. The miRNAs detected in each sample were 
categorized as up-, downregulated and no change with respect to untreated sample. (B) Venn 
diagram showing the distribution of unique and overlapping up-or downregulated miRNAs 
in response to individual LPS treatment.
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MiRNA expression kinetics in response to different incubation time and concentration of 
LPS. Changes in expression of miRNAs were monitored in THP1-differentiated 
macrophages over time (A) and (B) challenge dose of LPS. The levels of miR-29b, miR-32 
and miR-891 (down) and miR-146a (up) were evaluated by quantitative RT-PCR. RNU6B 
was used as an endogenous control. The expression levels in untreated cells were set at 1. 
The results shown here are the mean ± SD for three independent experiments. P-values were 
calculated using Student’s t-test. *P<0.05 compared to control.
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Dual luciferase reporter assays validate miRNA targets. (A, C, E, G) Luciferase reporter 
constructs were generated by cloning the 3′UTR of THBS1, SOCS4, IL6Rα or IFI30 
downstream of the Renilla luciferase gene. The cloned region of each 3′UTR is highlighted 
(rectangular box) and sequence alignment of the predicted miRNA binding site is also 
shown. (B, D, F, H) HEK293 cells were transiently co-transfected with reporter construct 
and either miRNA or negative control mimics. Constitutively expressed firefly luciferase 
readings were used for normalization. (1) Empty vector (EV) and miRNA mimic, (2) 
reporter construct with negative control mimic, (3-5) reporter construct and miRNA mimic 
at 1, 5 or 10 pmol. Error bars represent mean ± SD from three biological replicates. P-values 
were calculated using Student’s t-test. *P<0.0001 compared to control; # P<0.05 compared 
to 1 pmol (bar 3).
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MiR-29b and let-7f targets genes involved in immune responses. THP1 differentiated 
macrophages were transfected with miR-29b and let-7f mimics, inhibitors and negative 
control miRNA mimic at indicated final concentrations. After 36 hours, cellular levels of 
(A) IL-6Rα and (B) SOCS4 were analyzed by immunoblotting. GAPDH was used as 
internal control. Normalized levels of target proteins are shown graphically. The data is 
representative of three independent experiments.
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